A broad classification of inherited disorders presenting at birth that affect both the cell-mediated and humoral aspects of the immune response. Circulating numbers of B lymphocytes, T lymphocytes and...
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation for combined immunodeficiency is limited due to its broad classification and the rarity of specific genetic variants. As CID affects a small number of individuals worldwide, comprehensive clinical studies have been challenging to conduct. Additionally, the variability in clinical presentation complicates the establishment of standardized documentation.
To navigate combined immunodeficiency effectively, consider consulting with an immunologist who specializes in primary immunodeficiencies. It's also beneficial to seek genetic counseling to understand the implications of genetic testing for you and your family. While there are no patient organizations specifically identified for CID, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Additionally, inquire about participation in clinical trials to contribute to research and potentially access new therapies.
There are currently 64 active clinical trials related to combined immunodeficiency, which indicates ongoing research efforts to better understand and treat this condition. You can explore these trials further at ClinicalTrials.gov using the search term 'combined immunodeficiency'. While there are no orphan drug designations currently, the active trials may offer new insights and potential treatment avenues in the future.
Actionable guidance for navigating care for combined immunodeficiency
To navigate combined immunodeficiency effectively, consider consulting with an immunologist who specializes in primary immunodeficiencies. It's also beneficial to seek genetic counseling to understand the implications of genetic testing for you and your family. While there are no patient organizations specifically identified for CID, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Additionally, inquire about participation in clinical trials to contribute to research and potentially access new therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for combined immunodeficiency is limited due to its broad classification and the rarity of specific genetic variants. As CID affects a small number of individuals worldwide, comprehensive clinical studies have been challenging to conduct. Additionally, the variability in clinical presentation complicates the establishment of standardized documentation.
To navigate combined immunodeficiency effectively, consider consulting with an immunologist who specializes in primary immunodeficiencies. It's also beneficial to seek genetic counseling to understand the implications of genetic testing for you and your family. While there are no patient organizations specifically identified for CID, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Additionally, inquire about participation in clinical trials to contribute to research and potentially access new therapies.
There are currently 64 active clinical trials related to combined immunodeficiency, which indicates ongoing research efforts to better understand and treat this condition. You can explore these trials further at ClinicalTrials.gov using the search term 'combined immunodeficiency'. While there are no orphan drug designations currently, the active trials may offer new insights and potential treatment avenues in the future.
Actionable guidance for navigating care for combined immunodeficiency
To navigate combined immunodeficiency effectively, consider consulting with an immunologist who specializes in primary immunodeficiencies. It's also beneficial to seek genetic counseling to understand the implications of genetic testing for you and your family. While there are no patient organizations specifically identified for CID, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Additionally, inquire about participation in clinical trials to contribute to research and potentially access new therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for combined immunodeficiency is limited due to its broad classification and the rarity of specific genetic variants. As CID affects a small number of individuals worldwide, comprehensive clinical studies have been challenging to conduct. Additionally, the variability in clinical presentation complicates the establishment of standardized documentation.
To navigate combined immunodeficiency effectively, consider consulting with an immunologist who specializes in primary immunodeficiencies. It's also beneficial to seek genetic counseling to understand the implications of genetic testing for you and your family. While there are no patient organizations specifically identified for CID, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Additionally, inquire about participation in clinical trials to contribute to research and potentially access new therapies.
There are currently 64 active clinical trials related to combined immunodeficiency, which indicates ongoing research efforts to better understand and treat this condition. You can explore these trials further at ClinicalTrials.gov using the search term 'combined immunodeficiency'. While there are no orphan drug designations currently, the active trials may offer new insights and potential treatment avenues in the future.
Actionable guidance for navigating care for combined immunodeficiency
To navigate combined immunodeficiency effectively, consider consulting with an immunologist who specializes in primary immunodeficiencies. It's also beneficial to seek genetic counseling to understand the implications of genetic testing for you and your family. While there are no patient organizations specifically identified for CID, resources like the Genetic and Rare Diseases Information Center (GARD) at rarediseases.info.nih.gov can provide valuable information and support. Additionally, inquire about participation in clinical trials to contribute to research and potentially access new therapies.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.